Comment on: Relationship of serum magnesium and vitamin D levels in a nationally-representative sample of Iranian adolescents: The CASPIAN-III study by Nasri, Hamid. et al.
Letters to Editor
www.ijpm.inr
1482 International Journal of Preventive Medicine, Vol 5, No 11, November, 2014
Comment on: Relationship of Serum Magnesium and Vitamin D Levels in a 
Nationally-representative Sample of Iranian Adolescents: The CASPIAN-III Study
Hamid Nasri, Mohammad-Reza Ardalan1, Mahmoud Rafi eian-Kopaei2
DEAR EDITOR,
We read with great interest, the published 
article entitled “relationship of  serum magnesium 
and Vitamin D levels in a nationally-representative 
sample of  Iranian adolescents; the CASPIAN-III 
study” by Kelishadi et al. They aimed, to assess 
the association of  serum magnesium and Vitamin 
D (25(OH) D) levels in 330 students, aged range 
from 10 to 18 years. At this study, they found 
the significant association of  magnesium with 
25(OH) D serum levels. They suggested further 
considerations to find the underlying mechanisms 
and the clinical significance of  the current 
findings.[1] At this study, we would like to point out 
a few notes. In a cross-sectional investigation on a 
41 patients of  end-stage renal failure on regular 
hemodialysis, we found a significant positive 
correlation of  serum magnesium with 25 OH 
Vitamin D (r = 0.40, P = 0.009). This significant 
association was strongly positive in nondiabetic, 
diabetic, females, and male groups individually.[2] 
Recently, Gandhe et al., conducted a study to find 
out the probable correlation of  Vitamin D3, and 
magnesium levels in Type II diabetes mellitus 
cases. They firstly observed low magnesium 
levels in Type II diabetes mellitus subjects, as 
compared to healthy controls and secondly, 
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they detected a positive association of  Vitamin 
D with magnesium levels (r = 0.92, P < 0.01). 
They concluded that, Vitamin D levels can also 
influence the magnesium status. They additionally 
found the negative association of  magnesium with 
insulin resistance.[3] Hence, hypomagnesemia may 
leads to increased insulin resistance and as well 
established the fact that, low magnesium status, 
affects glucose metabolism too.[3-7] Fibroblast 
growth factor-23 is associated with atherosclerosis 
and cardiovascular mortality in chronic kidney 
disease patients and healthy subjects.[8-11] It was 
found that, magnesium deficiency increases serum 
fibroblast growth factor 23 levels too.[12] Thus, the 
positive association of  magnesium deficiency 
and fibroblast growth factor 23 increment,[1,12-16] 
further imply the significance of  magnesium 
deficiency and Vitamin D, while Vitamin D has 
a role in magnesium metabolism.[17] This finding 
is especially important in the pediatric group that 
elegantly detected by Kelishadi et al. Paper of  
Kelishadi et al., also had another message to further 
pay attention to fortified the micronutrients to the 
pediatrics, as a possible prevention of  progression 
of  renal failure in the pediatric population at risk 
too.
Nasri, et al.: Comment on: Relationship of serum magnesium and Vitamin D 
1483International Journal of Preventive Medicine, Vol 5, No 11, November, 2014
R EFERENCES
1. Kelishadi R, Ataei E, Ardalan G, Nazemian M, Tajadini M, 
Heshmat R, et al. Relationship of Serum Magnesium and 
Vitamin D Levels in a Nationally-Representative Sample 
of Iranian Adolescents: The CASPIAN-III Study. Int J 
Prev Med 2014;5:99-103.
2. Baradaran A, Nasri H. Correlation of serum magnesium 
with serum parathormone levels in patients on 
regular hemodialysis. Saudi J Kidney Dis Transpl 
2006;17:344-50.
3. Gandhe MB, Jain K, Gandhe SM. Evaluation of 25(OH) 
Vitamin D3 with Reference to Magnesium Status 
and Insulin Resistance in T2DM. J Clin Diagn Res 
2013;7:2438-41.
4. Nasri H, Rafi eian-Kopaei M. Signifi cant difference of 
serum 25-hydroxyvitamin D level in male hemodialysis 
patients with our without diabetes; a single center study. 
J Nephropharmacol 2012;1:3-4.
5. Ghorbani A, Baradaran A. Magnesium and diabetes 
mellitus. J Renal Inj Prev 2012;1:46-7.
6. Nasri H. Impact of diabetes mellitus on parathyroid 
hormone in hemodialysis patients. J Parathyr Dis 
2013;1:9-11.
7. Baradaran A. Beyond mineral metabolism, the bright 
immunomodulatory effect of vitamin D in renal disease. 
J Nephropharmacol 2012;1:17-8.
8. Asicioglu E, Kahveci A, Arikan H, Koc M, Tuglular S, 
Ozener C. Fibroblast growth factor-23 levels are 
associated with uric Acid but not carotid intima media 
thickness in renal transplant recipients. Transplant Proc 
2014;46:180-3.
9. Nasri H, Sahinfard N, Rafi eian M, Rafi eian S, Shirzad M, 
Rafi eian-kopaei M. Effects of Allium sativum on liver 
enzymes and atherosclerotic risk factors. J Herb Med 
Pharmacol 2013;2:23-8.
10. Roshan B, Stanton RC. A story of microalbuminuria and 
diabetic nephropathy. J Nephropathol 2013;2:234-40.
11. Behradmanesh S, Nasri H. Association of serum calcium 
with level of blood pressure in type 2 diabetic patients. 
J Nephropathol 2013;2:254-7.
12. Matsuzaki H, Kajita Y, Miwa M. Magnesium defi ciency 
increases serum fi broblast growth factor-23 levels in rats. 
Magnes Res 2013;26:18-23.
13. Nasri H. Impact of diabetes mellitus on parathyroid 
hormone in hemodialysis patients. J Parathyr Dis 
2013;2:1-2.
14. Hernandez GT, Nasri H. World kidney day 2014: 
Increasing awareness of chronic kidney disease and 
aging. J Renal Inj Prev 2014;3:3-4.
15. Hajivandi A, Amiri M. World kidney day 2014: Kidney 
disease and elderly. J Parathyr Dis 2014;2:5-6.
16. Rafieian-Kopaei M, Nasri H. Vitamin D therapy in 
diabetic kidney disease. J Nephropharmacol 2014;3:3-4.
17. Baradaran A. Primary hyperparathyroidism and kidney; 
recent fi ndings. J Parathyr Dis 2014;2:7-10.
Source of Support: Nil, Confl ict of Interest: None declared.
